Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Landos Biopharma Inc.

    NASDAQ: LABP · Real-Time Price · USD
    22.93
    0.13 (0.57%)
    At close: May 23, 2024, 8:00 PM

    Landos Biopharma Statistics

    Share Statistics

    Landos Biopharma has 3.13M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 3.13M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 4

    FTD / Avg. Volume

    n/a
    		 0.01%

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is -1.05 and the forward PE ratio is null. Landos Biopharma's PEG ratio is 0.02.

    PE Ratio

    n/a
    		 -1.05

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 0.72

    P/FCF Ratio

    n/a
    		 -1.12

    PEG Ratio

    n/a
    		 0.02
    Financial Ratio History

    Enterprise Valuation

    Landos Biopharma has an Enterprise Value (EV) of -14.58M.

    EV / Sales

    n/a
    		 0

    EV / EBITDA

    n/a
    		 0.64

    EV / EBIT

    n/a
    		 0.71

    EV / FCF

    n/a
    		 0.71

    Financial Position

    The company has a current ratio of 6.09, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 6.09

    Quick Ratio

    n/a
    		 6.09

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is -69% and Return on Invested Capital is -71.49%.

    Return on Equity

    n/a
    		 -69%

    Return on Assets

    n/a
    		 -57.66%

    Return on Invested Capital

    n/a
    		 -71.49%

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,154,473.68

    Employee Count

    n/a
    		 19

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 3.38% in the last 52 weeks. The beta is 0.14, so Landos Biopharma's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.14

    52-Week Price Change

    n/a
    		 3.38%

    50-Day Moving Average

    n/a
    		 19.89

    200-Day Moving Average

    n/a
    		 8.25

    Relative Strength Index (RSI)

    n/a
    		 77.26

    Average Volume (20 Days)

    n/a
    		 27,036

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -22.73M

    Net Income

    n/a
    		 -21.93M

    EBITDA

    n/a
    		 -22.73M

    EBIT

    n/a
    		 n/a

    Earnings Per Share (EPS)

    n/a
    		 -3.5
    Full Income Statement

    Balance Sheet

    The company has 37.55M in cash and 0 in debt, giving a net cash position of 37.55M.

    Cash & Cash Equivalents

    n/a
    		 37.55M

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 -155.36M

    Total Assets

    n/a
    		 29.9M

    Working Capital

    n/a
    		 23.15M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -20.48M and capital expenditures 0, giving a free cash flow of -20.48M.

    Operating Cash Flow

    n/a
    		 -20.48M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -20.48M

    FCF Per Share

    n/a
    		 -3.26
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    LABP does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -95.5%

    FCF Yield

    n/a
    		 -89.15%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for LABP.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on May 26, 2023. It was a backward split with a ratio of 1:10.

    Last Split Date

    n/a
    		 May 26, 2023

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:10

    Scores

    Altman Z-Score

    n/a
    		 -3.17

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist